Signals, Powered By EquityPandit
Jubilant Life Science has received US health regulator’s approval to market Indomethacin capsule, that are used for treating pains.
Jubilant Life Science said in a BSE filing that it “received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (USFDA) for Indomethacin ER Capsule 75mg, which is a non-steriodal anti-inflammatory drug used for treatment of pain”.
It further added that “this includes 72 ANDAs filed in the US, of which 38 have been approved and 46 Dossier filings in Europe.”
